Intrinsic Value of S&P & Nasdaq Contact Us

MBX Biosciences, Inc. Common Stock MBX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
53/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$55.33
+68.6%

Stock Statistics — MBX

MBX Biosciences, Inc. Common Stock (MBX) has a market capitalization of $1.1B and trades at $32.81. The 52-week range is 4.807-44.89.

Key metrics include a trailing Price-to-Earnings (P/E) ratio of -13.8, Earnings Per Share (EPS) of $-2.38.

The stock has a beta of 1.07, operates in the Healthcare sector.

Trading Data
Current Price$32.81
52-Week Range4.807-44.89
Volume450.66K
Avg Volume (30D)598.04K
Market Cap$1.1B
Beta (1Y)1.07
Company
IPO Date2000-01-14
Employees43
CEOPeter Kent Hawryluk
CountryUS
ExchangeNASDAQ Global Select
CurrencyUSD
ISINUS55287L1017
CUSIP55287L101
Income (Latest Year)
Gross Profit$-248K
EBITDA$-98.06M
Operating Income$-98.06M
Net Income$-86.97M
EPS$-2.38
EPS Diluted$-2.38
Shares Outstanding$36.51M
Balance Sheet (Latest Year)
Total Assets$385.14M
Current Assets$381.54M
Cash & ST Investments$373.71M
Total Liabilities$15.92M
Total Debt$596K
Net Debt$-74.69M
Total Equity$369.22M
Debt / Equity0.00
Valuation Ratios
P/E Ratio-13.8
P/B Ratio2.99
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message